• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

QLT:GR

2.915 EUR 0.146 5.27%

As of 14:54:10 ET on 12/18/2014.

Snapshot for QLT Inc (QLT)

Open: 2.819 Day's Range: 2.770 - 2.915 Volume: 0
Previous Close: 2.769 52wk Range: 2.662 - 5.091 1-Yr Rtn: -20.22%

Stock Chart for QLT

No chart data available.
  • QLT:GR 2.770
  • 1D
  • 1M
  • 1Y
2.769
Interactive QLT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QLT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2350
Est. PEG Ratio -
Market Cap (M EUR) 149.21
Shares Outstanding (M) 51.19
30 Day Average Volume 21
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 3.9153
Dividend Ex-Date 06/28/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QLT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for QLT

QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.

Jason M AryehChairmanGeoffrey F Cox "Geoff"Interim CEO
Sukhi JagpalChief Financial Officer
More Company Profile & Key Executives for QLT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil